Cryopreservation of ovarian tissue has been considered experimental for many years, but very recently the American Society of Reproductive Medicine is reviewing the process and perhaps soon will remove the label of "experimental" and recognize it as an established method for preserving female fertility when gonadotoxic treatments cannot be delayed or in patients before puberty or when there is desire to cryopreserve more than just few oocytes. This article discusses in detail the 3 methodologies used for cryopreservation: (a) slow freezing, (b) directional freezing, and (c) vitrification.
Introduction
Historically, the first successful freezing and re-transplant of ovarian tissue was performed and reported by Parkes and Smith. 1 However, despite thousands of papers published on freezing of ovarian slices (Google Scholar-accessed February 2019), this landmark paper was cited only 37 times. Excellent reviews on the topic can be found in Donnez and many others. [2] [3] [4] [5] [6] Fertility preservation is practiced today for women in their fertile years who for medical reasons (eg, undergoing chemotherapy or radiation) or life-style reasons (career choices, difficulty finding a partner) must postpone their time for pregnancy. [7] [8] [9] [10] [11] [12] Cryopreservation for cancer or medical reasons can rely on 3 main strategies used to safeguard women's future fertility, consisting of (a) temporary pituitary ovarian downregulation by GnRHa to minimize chemotherapy-associated gonadotoxicity, (b) cryopreservation of ovarian cortical slices, 13, 14 or (c) vitrification of oocytes. [15] [16] [17] [18] [19] Oocyte freezing is the main option chosen to electively postpone future fertility. Cryopreservation of ovarian tissue has been considered experimental for many years, but very recently the American Society of Reproductive Medicine (ASRM communication) is in the process of removing the label of "experimental" and recognize it as a method for preserving female fertility when gonadotoxic treatments cannot be delayed or in patients before puberty or when there is desire to cryopreserve more than just few oocytes. 20,21 A very interesting recent paper compared oocytes versus ovarian tissue cryopreservation for women facing cancer. 22 In this article, the 3 methodologies used for cryopreservation-slow freezing, directional freezing, and vitrificationwill be discussed in detail.
Conventional Slow Freezing
In conventional slow freezing, the tissue is cooled to temperatures below the freezing point with or without seeding and then, at a controlled cooling rate, slowly frozen to a temperature between -35°C and -130°C before plunging into liquid nitrogen (LN). 23 However, for many years, attempts to cryopreserve large tissue sections and whole organs have been ineffective because of problems associated with heat and mass transfer. 24 The heat transfer between the outer area and the center of large tissue sections creates nonhomogeneous rates of cooling between the core and the periphery. 25 In addition, large biological samples suffer from the long isothermal period caused by the massive release of latent heat occurring during the process of ice formation. 24, 26 The phenomenon of latent heat is caused by the energy generated by water molecules when they rejoin to form ice crystals. Such energy is released in the form of heat, which, in turn, causes a temperature rise of the surrounding structures. 27 The heat is normally transferred to the ice crystals just formed because they are made of conductive material. The consequence of this physical process is a transient thawing followed by refreezing, in a sequence that is repeated several times through the thickness of the tissue sample, causing severe cell damage. 28 Damages are usually reduced by keeping the ratio of surface to volume as high as possible, so that the excessive latent heat is removed by adjusting the cooling rate with the intent to achieve a uniform freezing. The smaller the sample, the faster the heat released from its inner part is removed, thus minimizing damages. However, the need of samples as small as possible is in contrast with the requirement of having a well-preserved large follicle population on thawing. It is also impossible to reduce the surface-to-volume ratio in samples like entire organs such as whole ovaries. Therefore, new strategies had to be implemented. The problem with mass transfer must be dealt both before freezing and, later, after thawing. Before freezing, the use of cryoprotectant (CP) solutions capable of penetrating in the tissue to a sufficient depth to reach every single cell in the tissue creates protection from ice damages. After thawing, the CP solutions must then be removed prior to transplantation because they can be toxic once the tissue or organ is at physiological temperature.
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Vitrification
Vitrification is a process in which ice crystal formation is avoided by exposing tissue or cells to high concentrations of CPs followed by rapid cooling by plunging into LN or in LN slush at temperatures of -210°C. 29 For many years, slow freezing, and not vitrification, was the method of choice for embryo cryopreservation. In 1985, the first successful vitrification of mouse embryos using a relatively large volume sample was reported. 30 As stated above, vitrification is the process in which a sample solidifies without the formation of ice crystals, thus resulting in a glassy amorphous state. The main factors that influence the probability for vitrification to occur are as follows: In 1989, the "minimum drop size" (MDS) method was developed by Arav. 19, 31 However, vitrification as a methodology for preserving large biological samples such as vascularized organs has many drawbacks: chemical toxicity and osmotic shock following exposure to very high (>50%) concentrations of CP solutions, fractures caused to the solidified organ by the vitrification procedure, 32 and devitrification if the storage temperature is above the glass transition temperature. 33 Vitrification is now the method of choice for preserving oocytes and embryos, but it is slowly gaining acceptance also for the gonadal tissue. However, the procedure is cumbersome, requires highly skilled personal, and is not standardized, thus producing variable results. We have recently developed a device for automatic vitrification of oocytes, embryos, and ovarian and testicular tissue 34 (see Figure 1 ). Having an automated device allowing the precise exposure of the tissue to cooling and warming solutions is desirable, particularly for preserving fertility for cancer patients. The device is fully automated (Sarah; FertileSafe Ltd, Israel) for both vitrification and warming of gonadal tissue slices in addition to oocytes and embryos. 34 A simplified, semiautomatic method has been recently introduced in the veterinary field (Ledda et al in press JASB 2019) using a special straw (called E.Vit) which stands for easy vitrification and is under the regulation review process for the human field.
Warming of Vitrified Tissue
To complete a successful cycle of vitrification/rewarming, it is extremely important to reach high warming rates. However, this is difficult to achieve in large tissue and organs. 33 The physical phenomenon of "heat transfer" is the limiting key factor that occurs during conventional warming (eg, when exposing vitrified tissue/cells to water bath). The slow warming rate is deleterious causing the formation of ice crystal growth during the warming stage (devitrification). Etheridge and colleagues 35 showed recently a new approach for rapidly and uniformly producing heating using radiofrequency (RF) excited by magnetic nanoparticles. We also showed a benefit of the RF system by applying the new concept of RF feedback technology. 36 In a simulation experiment, the new RF heating technology has been shown to be able to uniformly increase the warming rate of 150 mL of the solution mimicking a large size of tissue ( Figure 2 ).
Directional Freezing
An alternative technique to slow cooling is known as directional solidification or directional freezing. After the initial seeding stage (which is done automatically in the same device), the tissue sample (see Figure 3 ) is advanced at a constant velocity through a linear temperature gradient. This allows precise control over the freezing process, facilitating very accurate and homogeneous cooling of the tissue, with a controlled ice crystal growth, while the tissue sample is moved down the temperature gradient. Dissipation of heat from the sample is achieved primarily in 2 ways. The highly heat-conductive metal block surrounding the sample removes efficiently the heat away from the biological sample as it freezes. Because of the temperature gradient and the directional forward movement of the sample, the heat is continuously removed from the ice front into the unfrozen fraction of the sample that is still located at the higher temperature end of the thermal gradient. This controlled and directional heat dissipation protects the ice front from melting and refreezing, thus avoiding damages to the cells. All these processes result in highly controlled and "cellfriendly" ice crystal morphology that contributes significantly to reduce mechanical damages. [38] [39] [40] The efficient heat removal and the precisely controlled ice crystal propagation make it possible to use this technology to freeze small and large volumes alike. 41 As discussed, the cryopreservation of ovarian tissue is now a well-established method for preserving female fertility. 20, 21 This can be achieved through the excision and banking of the entire organ or of fragments of the ovarian cortex. However, whereas no live births or pregnancies have been achieved following the cryopreservation of whole human ovaries, more than 130 births have been obtained after re-transplantation of frozen-thawed ovarian cortical fragments. 6 This clearly suggests that the use of cortical fragments is the method of choice over whole ovary preservation. 3, 41 We have recently performed a direct comparison of sheep ovarian tissue viability between organs cryopreserved with a conventional programmable slow freezer or a directional freezing apparatus. 42, 43 Our results indicate that ovarian structures and functions were significantly better preserved by directional freezing.
The morphological analysis of ovarian tissue immediately after thawing showed that the use of directional freezing significantly improved the integrity of all follicular structures from primordial to secondary stages. In addition, consistent with the favorable effect of directional freezing on primordial follicle viability in vitro, we observed a higher cell proliferation rate compared with samples that underwent conventional freezing. However, so far, no clinical studies have been conducted with directional freezing of ovarian slices.
Freezing Large Organs: The Whole Ovary
One of the main drawbacks of ovarian tissue freezing and transplantation is the warm ischemia of the graft following transplantation.
In theory, the cryopreservation of whole ovaries followed by vascular anastomosis of the ovarian pedicle of the thawed organ should provide a larger follicular reserve and a longer life span of the transplant. However, currently available data do not support this hypothesis. This is largely due to the damages caused by the freezing procedures applied to a sample as large as a human ovary. We cryopreserved the whole ovary of sheep 44, 45 and human 46, 47 using directional freezing. In a comparative study on sheep, we found that directional freezing improves the viability of cryopreserved ovarian tissue when used not only with whole organs but also with ovarian fragments. 42, 43 The direct comparison of cortical fragments and whole organs unexpectedly revealed that the latter show a better preservation of early follicles in many aspects almost identical to those recorded in fresh control samples. However, the persistent technical difficulties linked to the surgical procedures required for re-transplantation are likely to still limit the use of whole ovaries in clinical settings. One more possibility is to freeze the whole ovary and to transfer cortical slices following the thawing.
Transplantation of the fresh whole ovary has been attempted with some success both in several animal species [48] [49] [50] [51] and in human, 9, 41 demonstrating that anastomosis of the ovarian pedicle is difficult but feasible. However, cryopreservation of the entire organ has proved difficult, largely due to the physical constraints that limit an appropriate heat transfer between the core and the periphery of the organ. 38 In addition, the large volume of the whole organ poses some limitations to the perfusion and diffusion of CPs. 52 Both are essential for preventing intravascular ice formation which would irreversibly compromise a rapid and efficient resumption of the blood supply. 26 An efficient protocol for the cryopreservation of the entire ovary would provide a possible way to improve the ischemic damages observed when avascular fragments are transplanted. However, current data obtained from experiments mostly performed in sheep do not support this hypothesis. Despite some positive results 53, 54 and pregnancies, 55 stromal and vascular damages of variable extent were observed both following slow freezing 56 as well as after vitrification. 31 To move forward ovarian cryopreservation, in the case of both avascular ovarian fragments and whole organs, requires an improvement of the freezing techniques. 20 A direct comparison between a conventional programmable slow freezer and the multi-thermal gradient (MTG) apparatus for the Figure 3 . Schematic principle of the "multi-thermal gradient" (MTG) freezing technology. After the initial seeding stage, the tissue sample is loaded and placed into the device (T1) and advanced at a constant velocity (V) through a linear temperature gradient (G1-G3). 37 
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